Galectin-3 is a beta-galactoside binding protein involved in various cellular processes and has recently been identified as a prognostic biomarker for HF, given its role in the pathophysiology of HF (Gehlken et al., 2018). This evidence concerns the gene LGALS3 and hydrops fetalis.